Kobre & Kim and Baker & Partners Announce Partnership with Bentham IMF to Investigate Alleged Overcharging by Patent Renewal Services Company CPA Global
International law firm Kobre & Kim, along with leading Jersey law firm Baker & Partners, announced today that they have entered into a funding arrangement with Bentham IMF to investigate and possibly sue CPA Global, alleging systematic and widespread overcharging of clients for patent renewal services. The firms are also working with the patent renewals consulting business Patent Annuity Costs Limited, headed by Peter Rouse.
CPA Global is one of the world’s largest patent renewal companies, reportedly processing more than 2 million patent renewals per year.
The potential actions will allege that CPA Global breached standard service contracts with what may be tens of thousands of clients through concealed mark-ups, in at least one case estimated to exceed 90 percent.
The proposed legal proceedings would be commenced in Jersey, one of the UK’s Channel Islands, where CPA Global is incorporated, on behalf of CPA Global clients whose agreements select Jersey as the forum for any disputes. Bentham IMF will provide non-recourse funding to CPA Global customers who wish to pursue claims against CPA Global.
James Corbett QC of Kobre & Kim, who is leading the investigation and proposed action, said the following:
"Based on the investigation so far, the overcharging could be shocking. Based on models, the aggregate over-charges could total hundreds of millions of dollars over a ten-year claim period."
Baker & Partners’ Senior Partner Stephen Baker said:
"We engaged with Bentham IMF to help clients enforce their rights on a risk-free basis without the need to secure representation. Given the international nature of CPA Global’s business, we have partnered with a global firm to work with our experienced Jersey team to seek effective redress for claimants from around the world."
Bentham IMF Investment Manager Matthew Harrison said:
"Patent holders worldwide contract with CPA Global for the renewal of rights associated with their most valued assets. CPA Global appears to have breached those contracts. Bentham IMF’s funding will enable Kobre & Kim and Baker & Partners to rectify CPA Global’s treatment of its customers while sparing the patent holders from incurring any fees and costs to participate in the litigation."
The potential litigation is funded by Bentham IMF. Participants will not be required to pay any fees unless their claim is successfully resolved, and then only from sums awarded by the Court.
CPA Global customers, past and present, can register for the potential action without charge or obligation at www.cpaglobal-litigation.com. To find out more about the investigation, please contact email@example.com or call global toll free number +1 833 204 1724.
About Bentham IMF
Bentham IMF is the U.S. arm of publicly listed IMF Bentham Limited (ASX: IMF), one of the most successful litigation funding companies in the world, with a portfolio that has a total claim size value of $3.8 billion AUD. Together, Bentham has 11 offices throughout the U.S., Australia, Canada and Asia and provides funding to clients in jurisdictions including the U.S., Australia, Canada, New Zealand, Hong Kong and Singapore. Bentham has reviewed thousands of commercial cases in the past 16 years, funding to completion more than 162 cases and generating $2.1 billion AUD in recoveries. It has achieved a 91% success rate, with clients utilizing Bentham funding retaining an average of 62% of all case proceeds. Information about Bentham can be found at https://www.benthamimf.com/.
About Kobre & Kim
Kobre & Kim is an Am Law 200 law firm focused exclusively on disputes and investigations, particularly international matters involving fraud or misconduct. Our Intellectual Property & Technology Litigation Group focuses on large-scale, cross-border litigation common in IP-related class actions. The team understands complex technology and has represented the world’s foremost research and academic institutions, as well as industry leaders with strong brands and market relationships. We recognize the importance of preserving our clients’ reputations when they engage in litigation, and we work from the outset to maintain their credibility both within and outside the legal proceedings. Our cross-disciplinary team is qualified in multiple jurisdictions across the U.S., Asia, EMEA and the Caribbean, and our global reach allows us to effectively advocate for clients around the world. Information about Kobre & Kim can be found at https://kobrekim.com/.
About Baker & Partners
Baker & Partners is a specialist litigation and dispute resolution practice based in Jersey. The firm has been at the forefront of some of the most complex and high value litigation in the Island. The firm specialises in fraud; asset tracing and recovery; civil and commercial litigation; trusts disputes; regulation and insolvency. The firm's clients include governments, high-net-worth individuals, professional services firms and local and international financial institutions. Baker & Partners’ lawyers have extensive practical experience in the courts of not only Jersey but also England and Wales. Their skills, both inside and outside of the courtroom, enable the firm to achieve clients’ aims in an efficient and cost-effective way. Further information can be located on the Baker & Partners website at http://www.bakerandpartners.com.
About Patent Annuity Costs Limited
Patent Annuity Costs Limited was created to address the specific needs of users of patent annuity payment providers arising from what is a stubbornly opaque market sector that patent holders are ill-equipped to address. The company has joined with procurement experts Positive Purchasing Limited to offer ‘Patent Plus’, a service that equips patent holders to identify opportunities for cost reduction and better manage their supplier relationships. Information about Patent Annuity Costs Limited can be found at http://www.pacipr.com/.
Kobre & Kim:
Stefanie Trilling, +1 646 448 6213
Baker & Partners:
Louise McNamee, +44 1534 766254
Patent Annuity Costs Limited:
Peter Rouse, +44 7737 128174
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Edgewater Networks Announces Event Sponsorship of BroadSoft Connections 201720.10.2017 21:00 | Pressemelding
Edgewater Networks, Inc., the industry leader in Network Edge Orchestration, announced today that it is an event sponsor of the BroadSoft Connections 2017 user conference, which takes place October 22-25 at the JW Marriott Phoenix Desert Ridge Resort & Spa in Phoenix, AZ. During the event, Edgewater Networks will feature demonstrations of the latest end-to-end network interoperability capabilities, including Zero Touch Provisioning, UC Analytics from the core to the endpoint, SD-WAN optimized for BroadSoft, and much more. Continuing a long-standing partnership with BroadSoft, Edgewater Networks has completed another level of BroadCloud certification, this time for local survivability which is critical for business continuity for SMB and Enterprise customers. BroadSoft’s PacketSmart is available on all EdgeMarc Intelligent Edges. All elements of the Network Edge Orchestration are
More than 70 Companies to Showcase Top Tech at CES Unveiled Paris20.10.2017 15:08 | Pressemelding
The Consumer Technology Association (CTA) today announced that more than 70 exhibitors will showcase their latest innovations at the now sold-out fifth annual CES Unveiled Paris The event will focus on the Internet of Things (IoT), connectivity and smart cities, and draw more than 600 attendees. CES Unveiled Paris will run from 2-7:30 PM on Tuesday, October 24, 2017 at the Palais Brongniart. Regional technology companies, top-tier media outlets, buyers and key industry influencers will come together at CES Unveiled Paris to get a direct look at the latest industry developments. The day kicks off with a CES news conference and CTA market trends presentation. Conference programming is followed by a tabletop exhibition & networking reception. Curated exhibitors will be there to showcase top tech from robotics and audio to smart home and augmented and virtual reality. Notable
Westinghouse Receives Regulatory Approval for Analysis Methodologies20.10.2017 12:15 | Pressemelding
Westinghouse Electric Company today announced that it has received approval from the U.S. Nuclear Regulatory Commission (NRC) for two new important analysis methodologies that will be used to upgrade Westinghouse- and Combustion Engineering-based nuclear steam supply system (NSSS) safety analyses. The approvals granted are for the new FULL SPECTRUMTM Loss of Coolant Accident (FSLOCATM) methodology and the Performance Analysis and Design Model software code update, PAD5. FSLOCA is capable of improved modeling of the transient response in a pressurized water reactor to the full spectrum of LOCA break sizes that could occur, and PAD5 is the next generation of the Westinghouse fuel rod design performance code. “These codes were developed to work in concert with each other to maximize analytical margin for nuclear utilities,” said Michele DeWitt, senior vice preside
Gilead Announces Multiple Scientific Presentations Demonstrating High Cure Rates in Difficult-to-Cure HCV Patients and Improved Long-Term Bone and Renal Safety of Vemlidy® in HBV Patients Switched from Viread®20.10.2017 12:03 | Pressemelding
Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from Phase 2 and Phase 3 studies of its approved medicines for chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection, adding to the body of evidence supporting Gilead’s viral hepatitis therapies in diverse patient populations. These and other data from more than 25 abstracts will be presented this week at The Liver Meeting® 2017, which begins today in Washington, D.C. Positive results from studies of Harvoni® (ledipasvir 90mg/sofosbuvir 400mg) in HCV-infected patients with severe renal impairment, Epclusa® (sofosbuvir 400mg/velpatasvir 100mg) in HCV-infected liver transplant recipients and Vosevi® (sofosbuvir 400mg/velpatasvir 100mg/voxilaprevir 100mg) in NS5A-inhibitor experienced HCV-infected patients will be presented during poster sessions on October 21 and October 22. In addition, updated results f
Schlumberger Announces Third-Quarter 2017 Results20.10.2017 11:00 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the third quarter of 2017. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2017 Jun. 30, 2017 Sept. 30, 2016 Sequential Year-on-year
SP3H Announces That It Has Obtained a €1.2 Million European Union Grant for Its Intelligent and Clean Vehicle (VIP) Project20.10.2017 10:47 | Pressemelding
SP3H is proud to announce joining the very select circle of the 10 French winners of the H2020 SME Instrument Phase 2 program since 2014. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171020005325/en/ Last summer VIP received the very prestigious SME instrument phase 2 H2020 label in the "transport & smart cities mobility" category. With an overall budget of € 1.7 million, VIP is subsidized by the European Union at a rate of 70% or €1.2 million. The framework contract was officially signed early October. VIP is the pre-industrialization program for Fuelbox sensors, the world's first miniaturized scanner capable of analyzing the quality of fuels on board vehicles. The heart of the program remains closely linked to the reduction of CO2 and pollutant emissions from vehicle
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom